Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84+0.01 (+0.97%)
Close on Nov 17, 2026Market cap $13.95MP/E –Yield –
Marker Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Marker Therapeutics's total assets was $14.59M at Jun 30, 2026. For fiscal 2025 it was $19.07M, down 13.4% from the year before. Over ten years it grew 11.1% a year on average. The highest annual figure on record is $68.14M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.07M | -13.4% |
| FY2024 | Dec 31, 2024 | $22.02M | +28.6% |
| FY2023 | Dec 31, 2023 | $17.13M | -50.2% |
| FY2022 | Dec 31, 2022 | $34.42M | -49.5% |
| FY2021 | Dec 31, 2021 | $68.14M | +49.4% |
| FY2020 | Dec 31, 2020 | $45.61M | -1.6% |
| FY2019 | Dec 31, 2019 | $46.36M | -25.4% |
| FY2018 | Dec 31, 2018 | $62.14M | +1099.6% |
| FY2017 | Dec 31, 2017 | $5.18M | -34.6% |
| FY2016 | Dec 31, 2016 | $7.92M | +19.2% |
| FY2015 | Dec 31, 2015 | $6.65M | +2860.8% |
| FY2014 | Dec 31, 2014 | $224.45K | +191.4% |
| FY2013 | Dec 31, 2013 | $77.03K | -11.8% |
| FY2012 | Dec 31, 2012 | $87.37K | -71.6% |
| FY2011 | Dec 31, 2011 | $307.92K | +164.5% |
| FY2010 | Dec 31, 2010 | $116.43K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $14.59M | -1.2% |
| Q1 FY2026 | Mar 31, 2026 | $17.43M | +2.6% |
| Q4 FY2025 | Dec 31, 2025 | $19.07M | -13.4% |
| Q3 FY2025 | Sep 30, 2025 | $21.73M | +99.2% |
| Q2 FY2025 | Jun 30, 2025 | $14.77M | +26.5% |
| Q1 FY2025 | Mar 31, 2025 | $16.99M | +20.6% |
| Q4 FY2024 | Dec 31, 2024 | $22.02M | +28.6% |
| Q3 FY2024 | Sep 30, 2024 | $10.91M | -44.0% |
| Q2 FY2024 | Jun 30, 2024 | $11.68M | -46.8% |
| Q1 FY2024 | Mar 31, 2024 | $14.09M | -49.6% |
| Q4 FY2023 | Dec 31, 2023 | $17.13M | -50.2% |
| Q3 FY2023 | Sep 30, 2023 | $19.49M | -52.6% |
| Q2 FY2023 | Jun 30, 2023 | $21.96M | -58.0% |
| Q1 FY2023 | Mar 31, 2023 | $27.94M | -49.2% |
| Q4 FY2022 | Dec 31, 2022 | $34.42M | -49.5% |
| Q3 FY2022 | Sep 30, 2022 | $41.11M | -42.8% |
| Q2 FY2022 | Jun 30, 2022 | $52.32M | -35.0% |
| Q1 FY2022 | Mar 31, 2022 | $54.96M | -37.8% |
| Q4 FY2021 | Dec 31, 2021 | $68.14M | +49.4% |
| Q3 FY2021 | Sep 30, 2021 | $71.94M | +48.1% |
| Q2 FY2021 | Jun 30, 2021 | $80.47M | +65.8% |
| Q1 FY2021 | Mar 31, 2021 | $88.36M | +106.0% |
| Q4 FY2020 | Dec 31, 2020 | $45.61M | -1.6% |
| Q3 FY2020 | Sep 30, 2020 | $48.57M | -5.5% |
| Q2 FY2020 | Jun 30, 2020 | $48.52M | -11.8% |
| Q1 FY2020 | Mar 31, 2020 | $42.89M | -27.3% |
| Q4 FY2019 | Dec 31, 2019 | $46.36M | -25.4% |
| Q3 FY2019 | Sep 30, 2019 | $51.40M | +551.4% |
| Q2 FY2019 | Jun 30, 2019 | $55.00M | +1776.9% |
| Q1 FY2019 | Mar 31, 2019 | $58.99M | +1038.7% |
| Q4 FY2018 | Dec 31, 2018 | $62.14M | +706.6% |
| Q2 FY2018 | Jun 30, 2018 | $7.89M | -22.2% |
| Q1 FY2018 | Mar 31, 2018 | $2.93M | -52.0% |
| Q4 FY2017 | Dec 31, 2017 | $5.18M | -34.6% |
| Q3 FY2017 | Sep 30, 2017 | $7.70M | -20.6% |
| Q2 FY2017 | Jun 30, 2017 | $10.14M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.11M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.92M | – |
| Q3 FY2016 | Sep 30, 2016 | $9.70M | – |
See a number that looks wrong?